Advertisement
U.S. markets closed

Neurobiological Technologies, Inc. (NTII)

Other OTC - Other OTC Delayed Price. Currency in USD
0.00000.0000 (0.00%)
At close: 02:04PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0000
Open0.0000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0000 - 0.0000
52 Week Range0.0000 - 0.0010
Volume107,300
Avg. Volume0
Market Cap10,862
Beta (5Y Monthly)-408.27
PE Ratio (TTM)
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for NTII

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • NEUROBIOLOGICAL TECHNOLOGIES IN
    BN: Lowering target price to $36.00BROOKFIELD CORP has an Investment Rating of BUY; a target price of $36.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    7 months agoArgus Research
View more
  • We're sorry we weren't able to find anything about this topic.